Evidence map›Paper›PMID 32369954›Full record

ArticleNanomaterials (Basel, Switzerland)2020

Bactericidal Silver Nanoparticles by Atmospheric Pressure Solution Plasma Processing.

Janith Weerasinghe, Wenshao Li, Rusen Zhou, Renwu Zhou, Alexander Gissibl, Prashant Sonar, Robert Speight, Krasimir Vasilev, Kostya Ken Ostrikov

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Biogenic Fabrication of Silver Nanoparticles UsingMaterials (Basel, Switzerland) · 2023
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Janith WeerasingheSchool of Chemistry and Physics, Queensland University of Technology, Brisbane 4000, Queensland, Australia.ORCID 0000-0002-2215-7450
Wenshao LiSchool of Biology and Environmental Science, Queensland University of Technology, Brisbane 4000, Queensland, Australia.
Rusen ZhouSchool of Mechanical, Medical and Process Engineering, Queensland University of Technology, Brisbane 4000, Queensland, Australia.
Renwu ZhouSchool of Chemical and Biomolecular Engineering, The University of Sydney, Sydney 2006, New South Wales, Australia.ORCID 0000-0003-1773-7095
Alexander GissiblSchool of Biology and Environmental Science, Queensland University of Technology, Brisbane 4000, Queensland, Australia.
Prashant SonarSchool of Chemistry and Physics, Queensland University of Technology, Brisbane 4000, Queensland, Australia.
Robert SpeightSchool of Biology and Environmental Science, Queensland University of Technology, Brisbane 4000, Queensland, Australia.ORCID 0000-0003-4161-8272
Krasimir VasilevSchool of Engineering, University of South Australia, Adelaide 5001, South Australia, Australia.
Kostya Ken OstrikovSchool of Chemistry and Physics, Queensland University of Technology, Brisbane 4000, Queensland, Australia.

Funding

Australian Research Council DP1810125
6 · The paper itself

Abstract

Silver nanoparticles have applications in plasmonics, medicine, catalysis and electronics. We report a simple, cost-effective, facile and reproducible technique to synthesise silver nanoparticles via plasma-induced non-equilibrium liquid chemistry with the absence of a chemical reducing agent. Silver nanoparticles with tuneable sizes from 5.4 to 17.8 nm are synthesised and characterised using Transmission Electron Microscopy (TEM) and other analytic techniques. A mechanism for silver nanoparticle formation is also proposed. The antibacterial activity of the silver nanoparticles was investigated with gram-positive and gram-negative bacteria. The inhibition of both bacteria types was observed. This is a promising alternative method for the instant synthesis of silver nanoparticles, instead of the conventional chemical reduction route, for numerous applications.

Indexed as

AC – DBD plasmaplasma production of nanoparticlessilver nanoparticles

Identifiers

PMID32369954
PMCPMC7279381

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.